↓ Skip to main content

Dove Medical Press

Article Metrics

Pharmacological management of binge eating disorder: current and emerging treatment options

Overview of attention for article published in Therapeutics and Clinical Risk Management, May 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#25 of 1,274)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
3 news outlets
blogs
3 blogs
twitter
9 tweeters
patent
14 patents
wikipedia
2 Wikipedia pages
video
2 video uploaders

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
185 Mendeley
Title
Pharmacological management of binge eating disorder: current and emerging treatment options
Published in
Therapeutics and Clinical Risk Management, May 2012
DOI 10.2147/tcrm.s25574
Pubmed ID
Authors

Susan McElroy, Anna I. Guerdjikova, Nicole Mori, Anne O’Melia

Abstract

Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder (BED), an eating disorder characterized by repetitive episodes of uncontrollable consumption of abnormally large amounts of food without inappropriate weight loss behaviors. In this paper, we provide a brief overview of BED and review the rationales and data supporting the effectiveness of specific medications or medication classes in treating patients with BED. We conclude by summarizing these data, discussing the role of pharmacotherapy in the BED treatment armamentarium, and suggesting future areas for research.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 185 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 3 2%
United States 1 <1%
Germany 1 <1%
Brazil 1 <1%
Unknown 179 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 17%
Student > Bachelor 31 17%
Student > Master 28 15%
Student > Ph. D. Student 20 11%
Student > Doctoral Student 12 6%
Other 31 17%
Unknown 32 17%
Readers by discipline Count As %
Medicine and Dentistry 50 27%
Psychology 43 23%
Agricultural and Biological Sciences 18 10%
Neuroscience 11 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Other 21 11%
Unknown 35 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 56. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2022.
All research outputs
#650,199
of 23,112,054 outputs
Outputs from Therapeutics and Clinical Risk Management
#25
of 1,274 outputs
Outputs of similar age
#3,310
of 164,456 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 12 outputs
Altmetric has tracked 23,112,054 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,274 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,456 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.